The effect of cloprostenol and cloprostenol + HCG on corpora lutea and serum progesterone in Brahman cows

Two independent trials were conducted to evaluate 1) the effect of cloprostenol (CLP; ICI 80996) on subsequent corpus luteum size and progesterone content and 2) the effect of CLP and CLP followed by HCG (1500 IU) at estrus on daily serum progesterone levels in Brahman cows.In Trial 1, cows were assigned as untreated controls (n=8) or to receive 500 μg CLP intramuscularly on day 8–12 postestrus (n=9). Corpora lutea were removed surgically and weighed on day 13 after the spontaneous or CLP induced estrus. CL progesterone (P4) was also monitored.In Trial 2, cows were assigned as untreated controls (n=15), to receive 500 μg CLP on day 9, 10 or 11 postestrus (n=10), or to receive CLP as above, plus 1500 IU HCG 12 hr after the CLP-induced estrus (n=10). Daily blood samples were collected from all cows from day 2 postestrus through the second estrus, thus encompassing the period of CL development and regression.The data generated in Trial 1 indicated that CLP depressed CL weight (2.7 vs 4.7 mg; P<.05) and CL P4 content (220.88 vs 367.43 μg; P<.05) as compared to untreated controls. Serum P4 during the time period corresponding with CL development was lower (P<.05) in CLP-treated cows in Trial 2. The most distinct reduction occurred from day 7 through 10. Postestrus treatment with 1500 IU HCG appeared to increase CL steroidogenic capacity, however, a significant (P<.05) difference was not detected between CLP + HCG and CLP or control groups.